Skip to main content
. 2021 Oct 4;8(6):687–695. doi: 10.4103/apjon.apjon-2124

Table 1.

Demographics and clinical characteristics n=128

Characteristics Intervention Group n=69, n(%) Control Group n=59, n(%) P
Age, years mean: 51.0 (SD, 10.2) mean: 55.4 (SD, 11.5) 0.02*,†
Gender
 Male 4 (5.8) 5 (8.5) 0.73
 Female 65 (94.2) 54 (91.5)
Marital status
 Married 52 (75.4) 47 (79.7) 0.42
 Single, divorces, or widowed 13 (18.8) 10 (17.0)
 No answer 4 (5.8) 2 (3.4)
Education
 Junior high school 1 (1.4) 4 (6.8) 0.62
 Senior high school 28 (40.6) 24 (40.7)
 Vocational school 10 (14.5) 8 (13.6)
 Junior college 13 (18.8) 12 (20.3)
 University, graduate school 15 (21.7) 9 (15.3)
 No answer 2 (2.9) 2 (3.4)
Employment status
 Employed 23 (33.3) 20 (33.9) 0.26
 Unemployed/retired 45 (65.2) 37 (62.7)
 No answer 1 (1.4) 2 (3.4)
Recurrence
 Yes 13 (18.8) 12 (20.3) 0.63
 No 39 (56.5) 26 (44.1)
 No answer 17 (24.6) 21 (35.6)
Cancer type
 Breast cancer 38 (55.1) 32 (54.2)
 Gynecological cancers 14 (20.3) 13 (22.0)
 Pancreatic and Gallbladder cancer 3 (4.3) 2 (3.4)
 Leukemia and Lymphoma 3 (4.3) 1 (1.7)
 Colorectal cancer 2 (2.9) 0
 Stomach cancer 2 (2.9) 2 (3.4)
 Lung cancer 1 (1.4) 4 (6.8)
 Renal and Urinary tract cancer 1 (1.4) 2 (3.4)
 Tongue cancer 1 (1.4) 1 (1.7)
 Peritoneal cancer 1 (1.4) 1 (1.7)
 Thyroid cancer 0 1 (1.7)
 Cancer of unknown origin 1 (1.4) 0
 No answer 2 (2.9) 0
Treatments (Multiple answers)
 Surgical treatment 63 54
 Chemotherapy 59 42
 Radiation therapy 21 14
 Hormone therapy 23 13
 others 1 1

SD: Standard deviation, *P<0.05, t-test, Chi-squared test